anti-miR-146a antisense oligonucleotide (Regulus Therapeutics)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Nameanti-miR-146a antisense oligonucleotide (Regulus Therapeutics)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionAntisense oligonucleotide inhibitors

TargetsUpdating

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRegulus Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRegulus Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsInflammation

Other Information

ATC CodeN/A